H&R GmbH & Co. KGaA (ETR:2HRA)

Germany · Delayed Price · Currency is EUR

5.40

-0.04 (-0.74%)

Jul 7, 2026, 5:35 PM CET

9.09% (1Y)

Market Cap	201.00M +9.5%
Revenue (ttm)	1.21B -11.0%
Net Income	-36.80M
EPS	-0.98
Shares Out	37.22M
PE Ratio	n/a
Forward PE	34.35
Dividend	0.10 (1.84%)
Ex-Dividend Date	n/a

Volume	280
Open	5.50
Previous Close	5.44
Day's Range	5.40 - 5.50
52-Week Range	3.91 - 5.68
Beta	0.38
Analysts	Sell
Price Target	4.30 (-20.37%)
Earnings Date	Aug 14, 2026

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the production and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts worldwide. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment offers paraffins, white oils, plasticizers, base oils, lubricants, and other crude-oil based specialty products, as well as bitumen, feedstocks, and bunker fuel. The ChemPharm Sales segment provides paraffins, plasticizers, wax emulsions, and other crude-oil based specialty produ... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1919

Employees 1,692

Stock Exchange Deutsche Börse Xetra

Ticker Symbol 2HRA

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2HRA stock is "Sell." The 12-month stock price target is €4.30, which is a decrease of -20.37% from the latest price.

Price Target

€4.30

(-20.37% downside)

Analyst Consensus: Sell

Stock Forecasts